ViiV

New name takes top spot in reputation ranking by US patient groups
Fierce Pharma
Tue, 05/14/24 - 11:14 pm
patient groups
reputation
Servier
Roche
ViiV
J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival
Fierce Pharma
Tue, 07/25/23 - 09:20 pm
JNJ
GSK
ViiV
Gilead Sciences
HIV
Cabenuva
Biktarvy
GSK's ViiV gives early look at HIV broadly neutralizing antibody's power, eyes long-acting combo trial
Fierce Biotech
Tue, 10/25/22 - 10:58 am
GSK
ViiV
bNab
N6LS
HIV
FDA Approvals Roundup: Cabenuva, Lupkynis, Verquvo
RAPS.org
Thu, 01/28/21 - 10:49 am
FDA
Cabenuva
HIV
ViiV
Aurinia
Lupkynis
Merck
Verquvo
3 Blockbuster Drug Launches to Watch This Year
Motley Fool
Sun, 01/24/21 - 03:24 pm
drug launches
GSK
Cabenuva
HIV
ViiV
Gilead Sciences
Trodelvy
Eli Lilly
Retevmo
cancer
FDA approves first monthly injectable to treat HIV infection
Stat
Thu, 01/21/21 - 11:45 pm
ViiV
FDA
Cabenuva
HIV
GSK and ViiV score breakthrough therapy designation in HIV prevention, as Truvada showdown draws nearer
Endpoints
Tue, 11/17/20 - 11:12 pm
GSK
ViiV
FDA
cabotegravir
HIV
PrEP
GSK’s ViiV Healthcare caps virtual HIV summit with a Facebook Live cabaret
Fierce Pharma
Sat, 11/14/20 - 09:56 pm
GSK
ViiV
HIV
Facebook
drug marketing
GSK reports its long-acting HIV PrEP tops Gilead's Truvada — again
Endpoints
Mon, 11/9/20 - 11:56 am
GSK
ViiV
cabotegravir
HIV
PrEP
FDA
Bayer, ViiV and RB challenge limits of pharma marketing creativity with innovative thinking, executions and media
Fierce Pharma
Tue, 11/3/20 - 09:41 pm
Bayer
ViiV
Reckitt Benckiser
pharma marketing
GSK
digital marketing
DTC advertising
GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen
Fierce Pharma
Mon, 10/5/20 - 11:45 am
GSK
ViiV
Dovato
HIV
ViiV, UNC-Chapel Hill renew HIV partnership for another five years
Pharma Times
Wed, 03/11/20 - 07:29 pm
HIV
ViiV
UNC-Chapel Hill
GSK's ViiV touts 2-month HIV data as sister injection Cabenuva awaits FDA redemption
Fierce Pharma
Mon, 03/9/20 - 10:39 am
HIV
FDA
GSK
Cabenuva
ViiV
Top GSK/ViiV scientist who co-invented an HIV blockbuster books a trip to biotech
Endpoints
Wed, 09/25/19 - 09:16 am
GSK
ViiV
Tivicay
HIV
HemoShear
HIV drugmakers ViiV, Gilead top 2018 pharma reputation survey
Fierce Pharma
Thu, 04/18/19 - 11:07 am
reputation
Gilead Sciences
ViiV
US filing for ViiV’s two-drug, single pill HIV treatment
Pharma Times
Mon, 10/22/18 - 05:03 pm
ViiV
FDA
HIV
dolutegravir/lamivudine
Should Gilead Be Worried About This New Monthly HIV Medication?
Motley Fool
Thu, 08/16/18 - 10:09 am
Gilead Sciences
HIV
JNJ
ViiV
cabotegravir
rilpivirine
Edurant
Long-acting injection boosts hopes for GSK's HIV business
Yahoo/Reuters
Wed, 08/15/18 - 09:40 am
GSK
HIV
AIDS
cabotegravir
rilpivirine
ViiV
Merck and ViiV are keeping it real with their TV ads. Which drugmakers will follow?
Fierce Pharma
Wed, 12/20/17 - 11:06 pm
Merck
ViiV
television ads
DTC ads
Fresh off its Juluca approval, GlaxoSmithKline beefs up trials of long-acting HIV duo
Fierce Pharma
Tue, 11/28/17 - 09:05 pm
GSK
cabotegravir
HIV
Endurant
ViiV
JNJ
Janssen

Pages